These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25766890)

  • 1. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
    Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
    Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
    Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
    J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11.
    Knapinska AM; Hart M; Drotleff G; Fields GB
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.
    Bhowmick M; Tokmina-Roszyk D; Onwuha-Ekpete L; Harmon K; Robichaud T; Fuerst R; Stawikowska R; Steffensen B; Roush W; Wong HR; Fields GB
    J Med Chem; 2017 May; 60(9):3814-3827. PubMed ID: 28394608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for targeting matrix metalloproteinases.
    Fields GB
    Matrix Biol; 2015; 44-46():239-46. PubMed ID: 25595836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for the Construction of Collagen-Based Triple-Helical Peptides Designed as Matrix Metalloproteinase Inhibitors.
    Fields GB
    Methods Mol Biol; 2019; 1944():229-252. PubMed ID: 30840247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.
    Ndinguri MW; Bhowmick M; Tokmina-Roszyk D; Robichaud TK; Fields GB
    Molecules; 2012 Nov; 17(12):14230-48. PubMed ID: 23201642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
    J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
    Lauer-Fields JL; Whitehead JK; Li S; Hammer RP; Brew K; Fields GB
    J Biol Chem; 2008 Jul; 283(29):20087-95. PubMed ID: 18499673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
    Fields GB
    Front Immunol; 2019; 10():1278. PubMed ID: 31214203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
    Lauer-Fields JL; Minond D; Chase PS; Baillargeon PE; Saldanha SA; Stawikowska R; Hodder P; Fields GB
    Bioorg Med Chem; 2009 Feb; 17(3):990-1005. PubMed ID: 18358729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of Matrix Metalloproteinases in Pancreatic Cancer.
    Knapinska AM; Estrada CA; Fields GB
    Prog Mol Biol Transl Sci; 2017; 148():339-354. PubMed ID: 28662827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).
    Higashi S; Hirose T; Takeuchi T; Miyazaki K
    J Biol Chem; 2013 Mar; 288(13):9066-76. PubMed ID: 23395821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
    Fields GB
    Cells; 2019 Aug; 8(9):. PubMed ID: 31461880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
    Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
    Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.